Imualfa 1.6mg Injection

By Imualfa

Rx

1 Injection in a Vial

Composition icon

Composition

Thymosin alpha(1.6mg)

Manufacturer - Alniche Life Sciences Pvt Ltd icon

Manufacturer - Alniche Life Sciences Pvt Ltd

Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027

Expires on or after icon

Expires on or after

April, 2026

About Imualfa 1.6mg Injection

Imualfa 1.6mg Injection is a powerful antiviral medication utilized for treating chronic hepatitis B virus (HBV) infections. This injection works by enhancing the immune system’s ability to fight against the virus, thereby aiding in the treatment of the infection. It is important to note that Imualfa 1.6mg Injection should only be administered by a healthcare professional and should not be self-administered.

Throughout the course of treatment with Imualfa 1.6mg Injection, patients may undergo regular monitoring of their liver function through various tests. It is crucial to follow these monitoring procedures to ensure the drug's effectiveness and to detect any potential complications that may arise during treatment. It is advised that immunocompromised individuals, such as organ transplant patients, should not receive this medication due to its impact on immunity.

Common side effects associated with Imualfa 1.6mg Injection include joint pain, decreased muscle tone, and skin rash. In addition, some patients may also experience injection site reactions like pain, swelling, or redness. If any of these side effects persist or worsen, it is recommended to inform your healthcare provider promptly. Furthermore, individuals who are pregnant, planning to conceive, or breastfeeding should consult their doctor before initiating treatment with this medication to ensure safety for both the individual and the baby.


Benefits

Imualfa 1.6mg Injection offers significant benefits in the treatment of Chronic Hepatitis B virus (HBV) infection. This medication is designed to stop the HBV virus from replicating within the body, thus helping to manage the infection effectively. By controlling the virus, Imualfa 1.6mg Injection supports the immune system in functioning better, ultimately reducing the likelihood of complications and enhancing the overall quality of life for individuals affected by HBV.

It is essential to note that Imualfa 1.6mg Injection is intended for use in combination with other antiretroviral drugs and is not a cure on its own. This medication should not be used as a preventative measure against HBV infection. To ensure optimal benefits, Imualfa 1.6mg Injection should only be administered by a healthcare professional such as a doctor or nurse, and self-administration should be strictly avoided.

Adhering to the prescribed dosage and schedule is crucial for maximizing the effectiveness of Imualfa 1.6mg Injection. Taking the medication consistently and as directed can significantly improve treatment outcomes and enhance its ability to manage HBV infection. By following the medical guidance provided, patients can experience the full benefits of Imualfa 1.6mg Injection in controlling the virus, boosting immune function, and ultimately improving their overall well-being.


How to use the Imualfa 1.6mg Injection

When you receive Imualfa 1.6mg Injection, it is important that only a qualified healthcare professional, specifically your doctor or nurse, administers the medication. This injection should not be self-administered under any circumstances. Your healthcare provider will determine the appropriate dosage and administration method based on your individual needs and medical condition. It is crucial to adhere to their instructions precisely to ensure the safe and effective use of Imualfa 1.6mg Injection. If you have any questions or concerns about the administration process, do not hesitate to consult your healthcare provider for clarification and guidance. By following these guidelines, you can optimize the benefits of this medication while minimizing the risks associated with improper use.


Uses of Imualfa 1.6mg Injection

Imualfa 1.6mg Injection is indicated for the treatment of chronic hepatitis B virus (HBV) infection. It is a medication that helps manage this condition by targeting the HBV virus. This injection is specifically designed to be effective in treating chronic HBV infection, which is a long-term viral infection that attacks the liver. Imualfa 1.6mg Injection is recommended for patients diagnosed with chronic HBV infection to help control the virus and improve liver health.


What conditions Imualfa 1.6mg Injection treats?

Imualfa 1.6mg Injection is used for treating chronic hepatitis B virus (HBV) infection. It works by preventing the virus from multiplying in the body, which helps improve the immune system's function. This medication is always used alongside other antiretroviral drugs. It does not cure HBV but helps in controlling the infection, reducing complications, and enhancing the quality of life. It should be administered by a healthcare professional, with regular monitoring of liver function tests throughout the treatment. Note that it is not suitable for immunocompromised individuals. Some common side effects include joint pain, decreased muscle tone, skin rash, and injection site reactions. If these persist, consult your doctor.


Should you consult a doctor?

If you experience any concerning symptoms while using Imualfa 1.6mg Injection for chronic hepatitis B, it is important to seek medical advice promptly. Contact your healthcare provider if you notice persistent side effects such as joint pain, decreased muscle tone, or skin rash. Additionally, if you encounter any injection site reactions like pain, swelling, or redness that do not improve or worsen over time, consult with your doctor.

It is advisable to inform your healthcare provider if you are pregnant, planning to conceive, or breastfeeding before starting treatment with Imualfa 1.6mg Injection. Patients with suppressed immunity, such as organ transplant recipients, should avoid this medication. Regular monitoring of liver function tests by a healthcare professional throughout the treatment course is essential.

Remember not to self-administer Imualfa 1.6mg Injection and always follow the guidance of a qualified medical practitioner for proper administration and monitoring. Your doctor can provide personalized advice and address any concerns you may have related to the treatment.


Side effects of Imualfa 1.6mg Injection

Some side effects may occur while using Imualfa 1.6mg Injection. These side effects are usually not serious and may go away as your body gets used to the medication. It is important to speak with your doctor if any of these side effects bother you or do not go away. These side effects may include hypotonia, which is a decrease in muscle tone that may cause weakness or floppiness in muscles. Joint pain is another possible side effect, where you may experience discomfort or achiness in your joints. Additionally, a skin rash may develop, which can appear as red, itchy patches on the skin. If you experience any of these side effects, it is advisable to seek guidance from your healthcare provider.


Safety advice

scroll

liver

Imualfa 1.6mg Injection is considered safe for use in individuals with liver disease. Current data indicates that adjusting the dosage of Imualfa 1.6mg Injection may not be necessary for patients with liver conditions. It is recommended to seek guidance from your healthcare provider before using this medication, especially if you have liver issues.

scroll

kidney

Limited information is present regarding the use of Imualfa 1.6mg Injection in patients with kidney disease. It is advisable to consult with your doctor for guidance.

scroll

alcohol

It is not known whether drinking alcohol is safe while using Imualfa 1.6mg Injection. Please consult your doctor.

scroll

driving

It is uncertain if Imualfa 1.6mg Injection impacts driving ability. Avoid driving if you have symptoms hindering focus and reactions.

scroll

pregnancy

Imualfa 1.6mg Injection is considered unsafe for use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor for more information.

scroll

breastfeeding

It is better to consult your doctor before using Imualfa 1.6mg Injection.


Consumption warning before consuming Imualfa 1.6mg Injection

Before consuming Imualfa 1.6mg Injection for chronic hepatitis B virus (HBV) infection, it's crucial to note some key warnings. This antiviral medication should only be administered by a healthcare professional and should not be self-administered. Throughout the treatment, regular monitoring of liver function tests is necessary. It is important to avoid giving this injection to immunocompromised individuals or those with suppressed immunity, such as organ transplant patients. Common side effects may include joint pain, decreased muscle tone, and skin rash, as well as injection site reactions like pain, swelling, or redness. If these side effects persist, it is essential to consult your doctor. Additionally, if you are pregnant, planning to conceive, or breastfeeding, consulting your healthcare provider before taking Imualfa 1.6mg Injection is advisable.


What if you forgot to take Imualfa 1.6mg Injection?

If you forget to take your scheduled dose of Imualfa 1.6mg Injection, try to take it as soon as you remember. But if it's near the time for your next dose, skip the missed one and continue with your usual dosing schedule. It's important not to take a double dose to make up for the missed one. Be sure to follow your healthcare provider's instructions carefully to maintain the effectiveness of your treatment.


Related lab tests

For evaluating the effectiveness and potential side effects of Imualfa 1.6mg Injection, several related lab tests are recommended to monitor the patient's health. These include tests for Hepatitis B (Core) IgM Antibody, Hepatitis B s (Surface) Antigen, and Hepatitis C Virus Total Antibody. These tests help in assessing any possible viral infections or reactions that may occur during the course of treatment with Imualfa 1.6mg Injection. Monitoring these specific lab tests can provide valuable insights into the patient's immune response and overall health status while undergoing treatment.


Additional Information

Habit FormingNo
Chemical ClassPeptides
Therapeutic ClassANTI INFECTIVES
Action ClassBiological response modifier- Thymosin alpha

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

2400

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 11-Feb-2025